Mohamed H. S. Awwad

Mohamed H. S. Awwad

Auto-generated profile, based on publicly available information

Mohamed H. S. Awwad

Department of Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
STStephan M. Tirier
Stephan M. Tirier
JMJan-Philipp Mallm
Jan-Philipp Mallm
SSSimon Steiger
Simon Steiger
APAlexandra M. Poos
Alexandra M. Poos
MAMohamed H. S. Awwad
Mohamed H. S. Awwad
KRKarsten Rippe
Karsten Rippe
Virtually all patients with multiple myeloma become unresponsive to treatment over time. Relapsed/refractory multiple myeloma (RRMM) is accompanied by the clonal evolution of myeloma cells with heterogeneous genomic aberrations and profound changes of the bone marrow microenvironment (BME). However, the molecular mechanisms that drive drug resistance remain elusive. Here, we analyze the heterogeneous tumor cell population and its complex interaction network with the BME of 20 RRMM patients by single cell RNA-sequencing before/after treatment. Subclones with chromosome 1q-gain express a specific transcriptomic signature and frequently expand during treatment. Furthermore, RRMM cells shape an immune suppressive BME by upregulation of inflammatory cytokines and close interaction with the myeloid compartment. It is characterized by the accumulation of PD1+γδ T-cells and tumor-associated macrophages as well as the depletion of hematopoietic progenitors. Thus, our study resolves transcriptional features of subclones in RRMM and mechanisms of microenvironmental reprogramming with implications for clinical decision-making.

29 November 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
RLRaphael Lutz
Raphael Lutz
FGFlorian Grünschläger
Florian Grünschläger
MSMalte Simon
Malte Simon
MAMohamed H. S. Awwad
Mohamed H. S. Awwad
MBMarcus Bauer
Marcus Bauer
SHSimon Haas
Simon Haas
The long-term consequences of cancer and its therapy on the patients’ immune system years after cancer-free survival remain poorly understood. Here, we present an in-depth characterization of the bone marrow immune ecosystem of multiple myeloma long-term survivors, from initial diagnosis up to 17 years following a single therapy line and cancer-free survival. Using comparative single-cell analyses combined with molecular, genomic, and functional approaches, we demonstrate that multiple myeloma long-term survivors exhibit pronounced alterations in their bone marrow microenvironment associated with impaired immunity. These immunological alterations were frequently linked to an inflammatory immune circuit fueled by the long-term persistence or resurgence of residual myeloma cells. Notably, even in the complete absence of any detectable residual disease for decades, sustained changes in the immune system were observed, suggesting an irreversible ‘immunological scarring’ caused by the initial exposure to the cancer and therapy. Collectively, our study provides key insights into the molecular and cellular bone marrow ecosystem of long-term survivors of multiple myeloma, revealing both reversible and irreversible alterations in the immune compartment.

3 June 2024 in Leukemia
Verified
Journal Article
Open access
PDF file
KKKatharina Kriegsmann
Katharina Kriegsmann
GTGigi Nu Hoang Quy Ton
Gigi Nu Hoang Quy Ton
MAMohamed H. S. Awwad
Mohamed H. S. Awwad
ABAxel Benner
Axel Benner
UBUta Bertsch
Uta Bertsch
MHMichael Hundemer
Michael Hundemer

4 April 2023
Verified
Other
Open access
DMDimitrios Mougiakakos
Dimitrios Mougiakakos
CBChristian Bach
Christian Bach
Martin BöttcherMartin Böttcher
Martin Böttcher
FBFabian Beier
Fabian Beier
LRLinda Röhner
Linda Röhner
HBHeiko Bruns
Heiko Bruns
Supplemental Figures 1-24 and Tables 1-3

4 April 2023
Verified
Other
Open access
DMDimitrios Mougiakakos
Dimitrios Mougiakakos
CBChristian Bach
Christian Bach
Martin BöttcherMartin Böttcher
Martin Böttcher
FBFabian Beier
Fabian Beier
LRLinda Röhner
Linda Röhner
HBHeiko Bruns
Heiko Bruns
Supplemental Figures 1-24 and Tables 1-3